NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Orbis Diagnostics

Orbis Diagnostics

Private
AucklandHealthcare & Life Scienceshttps://www.orbisdiagnostics.com/

Last Round

VC Round

May 30, 2025

Total Funding Raised

$3.67M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Orbis Diagnostics is a healthtech company that is developing a point-of-care diagnostics platform capable of delivering clinically-accurate blood test results from a single fingerstick of blood.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticsPOCTlab-on-a-discrapid blood testingmicrofluidic technologyquantitative immunoassaydiagnostic platformimmunity testingMedTechmultiplex testingbiomarker analysisdiagnostic consumablesanimal health diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbis Diagnostics Comps

Public and private peers based on sector, stage, and business model.

Orbis Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orbis Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 30, 2025
GrantAug 1, 2024
SeedMay 20, 2022
Series ANov 16, 2021
VC RoundOct 12, 2020

Key People

Founding team and executive leadership

Cather Simpson

Chief Executive Officer

Executive Team

Orbis Diagnostics Investors

Notable investors and investment history

Orbis Diagnostics investors
InvestorRounds
Callaghan InnovationGrant
Even CapitalSeed, Series A
Booster Innovation FundSeed
Pacific ChannelVC Round, Series A
Clare VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 6, 2026

    Grew 19% QoQ, from 16 to 19 employees.

  • Mar 19, 2026

    Grew 19% QoQ, from 16 to 19 employees.

Orbis Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orbis Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orbis Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuckland
Employee Range19
Year Founded2016
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.